新型化合物作为治疗抑郁症的5‐HT2A激动剂
1Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
开发出了新型化合物,作为血清素5-HT2A激动剂. 这些化合物为治疗抑郁症提供了一种新的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 药用化学 医学化学
背景情况:
- 胺5-HT2A受体与各种神经功能有关.
- 血清素通路的调节失调与抑郁症等情绪障碍有关.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
G-protein Coupled Receptors
